Endocrinol Metab.
2013 Sep;28(3):221-225. 10.3803/EnM.2013.28.3.221.
Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist
- Affiliations
-
- 1Department of Internal Medicine, Cheil General Hospital & Women's Healthcare Center, Kwandong University College of Medicine, Seoul, Korea. changhoon.yim@cgh.co.kr
- KMID: 1973827
- DOI: http://doi.org/10.3803/EnM.2013.28.3.221
Abstract
- Gonadotropin-releasing hormone (GnRH) agonist has been used in the treatment of a wide variety of sex-hormone-related diseases, as the administration of GnRH agonist can alter the secretion of gonadotropin and sex hormones. Recently, we found that the long-acting GnRH agonist aggravated hyperthyroidism and induced painless thyroiditis. This is the first report to demonstrate the association of thyroid dysfunction with GnRH agonist injection in Korea. Here, we report three cases and emphasize the clinical importance of this aggravating factor in autoimmune thyroid disease.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The effective of ultrashort-term gonadotropin-releasing hormone agonist administration in controlled ovarian hyperstimulation for in vitro fertilization
- Indication of Gonadotropin-Releasing Hormone Agonist: Precocious Puberty or Advanced Puberty?
- A study of low dose purified follicle-stimulating hormone supplemented with gonadotropin releasing hormone agonist in women with polycystic ovarian disease
- Direct modulatory action of gonadotropin releasing hormone agonist on ovarian function : Effect on progesterone production in FSH-stumilated procine granulosa cell culture
- Efficacy and Side Effects of GnRH Agonist
